Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2026-01-03 @ 5:22 PM
Study NCT ID:
NCT04612894
Status:
UNKNOWN
Last Update Posted:
2020-11-03
First Post:
2020-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer
Sponsor:
Fudan University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-10-30
First Submit QC Date:
None
Study First Post Date:
2020-11-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-02
Last Update Post Date:
2020-11-03
Last Update Post Date Type:
ACTUAL